1 – 10 of 76
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Factor VIII genotype and the risk of developing high-responding or low-responding inhibitors in severe hemophilia A : data from the PedNet Hemophilia Cohort of 1,202 children
- Contribution to journal › Article
-
Mark
Prior cancer and risk of monoclonal gammopathy of undetermined significance : a population-based study in Iceland and Sweden
- Contribution to journal › Article
- 2023
-
Mark
Engineered human Diamond-Blackfan anemia disease model confirms therapeutic effects of clinically applicable lentiviral vector at single-cell resolution
- Contribution to journal › Article
-
Mark
IL1RAP is expressed in several subtypes of pediatric acute lymphoblastic leukemia and can be used as a target to eliminate
ETV6::RUNX1-positive leukemia cells in preclinical models.
- Contribution to journal › Article
- 2022
-
Mark
Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations
- Contribution to journal › Letter
-
Mark
Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen - a real world study on patients diagnosed in Sweden 2007-2017
- Contribution to journal › Letter
-
Mark
Successful gene therapy of Diamond-Blackfan anemia in a mouse model and human CD34+ cord blood hematopoietic stem cells using a clinically applicable lentiviral vector
- Contribution to journal › Article
- 2021
-
Mark
Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B : a PedNet study
- Contribution to journal › Article
-
Mark
Combinatorial molecule screening identifies a novel diterpene and the BET inhibitor CPI-203 as differentiation inducers of primary acute myeloid leukemia cells
- Contribution to journal › Article
-
Mark
Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance
- Contribution to journal › Article
